Intellectual Property India Publishes Patent Application for 'Lipid Nanoparticles For The Prevention Of Tuberculosis Or Other Mycobacterial Infections' Filed by Akagera Medicines, Inc.

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517068248 A) filed by Akagera Medicines, Inc., Boxford, U.S.A., on July 17, for 'lipid nanoparticles for the prevention of tuberculosis or other mycobacterial infections.'

Inventor(s) include Fulton, Ross; Drummond, Daryl, C; Friedman, Robin; Cobaugh, Christian; and Hayes, Mark, E.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "Aspects of the present disclosure provides for improved mycobacterium tuberculosis vaccine compositions of ionizable lipid nanoparticles for the delivery of immunogenic nucleic acids to cells. Anionic phospholipids, i...